Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4611 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=UREBDLICKHMUKA-DVTGEIKXSA-N
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4611 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:58 UTC 2023
by
admin
on
Fri Dec 15 15:12:58 UTC 2023
|
Record UNII |
9842X06Q6M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QS03BA03
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
CFR |
21 CFR 524.1044D
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
CFR |
21 CFR 524.1044I
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
R03BA04
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
CFR |
21 CFR 524.1044B
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QA07EA04
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
D07AC01
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
492415
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QD07BC01
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
D07CC01
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
S01BB04
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QD07CC01
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QR03BA04
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
S01CA05
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QS02CA90
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
S01CB04
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
A07EA04
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.3
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QS01BA06
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
H02AB01
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
S01BA06
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
CFR |
21 CFR 524.1044G
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QD07XC01
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QS01CB04
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QH02AB01
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
CFR |
21 CFR 524.1044F
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
R01AD06
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
D07XC01
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QC05AA05
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
S02BA07
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QS03CA06
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
D07BC01
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
LIVERTOX |
100
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QS01BB04
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
S03CA06
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-ATC |
S03BA03
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QD07AC01
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QS01CA05
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-ATC |
C05AA05
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
||
|
WHO-VATC |
QR01AD06
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
||
|
WHO-VATC |
QS02BA07
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1514
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | RxNorm | ||
|
3077
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
m2452
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | Merck Index | ||
|
D001623
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
Betamethasone
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
CHEMBL632
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
SUB05797MIG
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
C303
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
100000091947
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
BETAMETHASONE
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | Description: A white or creamy white powder; odourless. Solubility: Practically insoluble in water; sparingly soluble in ethanol (~750 g/l) TS. Category: Adrenoglucocorticoid. Storage: Betamethasone should be kept in a tightly closed container, protected from light. Definition: Betamethasone contains not less than 96.0% and not more than 104.0% of C22H29FO5 calculated with reference to the dried substance. | ||
|
BETAMETHASONE
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
DTXSID3022667
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
3015
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
9782
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
1045
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
Betamethasone, Topical
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
378-44-9
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
9842X06Q6M
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
1066009
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
9842X06Q6M
Created by
admin on Fri Dec 15 15:12:58 UTC 2023 , Edited by admin on Fri Dec 15 15:12:58 UTC 2023
|
PRIMARY | |||
|
39470
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
DB00443
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
206-825-4
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
348
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY | |||
|
7061
Created by
admin on Fri Dec 15 15:12:59 UTC 2023 , Edited by admin on Fri Dec 15 15:12:59 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DEGRADENT -> PARENT |
When catalyzed by sulfuric acid only.
|
||
|
DEGRADENT -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (UV)
EP
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
http://apps.who.int/phint/pdf/b/Jb.6.1.56.pdf
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||